Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps
Disc Medicine Inc (IRON)
Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update
Quoin Pharmaceuticals Ltd DRC (QNRX)
Quoin Pharmaceuticals Announces Second Quarter 2025 Financial Results and Corporate Update
STRATA Skin Sciences Inc (SSKN)
SELLAS Life Sciences Group Inc. (SLS)
Sellas Life Sciences - SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification
Intelligent Bio Solutions Inc (INBS)
Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum
Processa Pharmaceuticals Inc. (PCSA)
New Form 8-K - Processa Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0001493152-25-011680 Size: 484 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Journey Medical Corporation (DERM)
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
Processa Pharmaceuticals Inc. (PCSA)
Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
Intelligent Bio Solutions Inc (INBS)
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum
SELLAS Life Sciences Group Inc. (SLS)
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification
Fortress Biotech Inc. (FBIOP)
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11